Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary plasma cell leukemia occuring in the young.

R S Raj1, S Najeeb, R Aruna

  • 1Medical College Hospital, Thiruvananthapuram - 695 011, India.

Indian Journal of Cancer
|January 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials.

Scientific reports·2026
Same author

Bulk and surface engineered drug delivery system of repurposed drug enhances low-dose gemcitabine efficacy in pancreatic cancer.

International journal of pharmaceutics·2025
Same author

Optimizing medication therapy in elderly patients: The impact of medication review using STOPP and START criteria version 2.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2024
Same author

Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer.

Molecular pharmaceutics·2024
Same author

Health technology assessment for digital health Technologies in India: a framework for action.

International journal of technology assessment in health care·2024
Same author

Integrative management of insomnia during cancer chemotherapy: A case report.

Journal of Ayurveda and integrative medicine·2024

Plasma Cell Leukemia (PCL) is a rare aggressive blood cancer. This case report details an extremely rare primary PCL presentation in a 21-year-old, highlighting the disease

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Plasma Cell Leukemia (PCL) is a rare and aggressive plasma cell dyscrasia.
  • PCL presents either primarily (de novo) or secondarily, as a transformation of multiple myeloma (MM).
  • Typically, PCL affects individuals over 50 years old, with a more aggressive clinical course than MM.

Observation:

  • This report describes an exceptionally rare case of primary PCL in a 21-year-old patient.
  • The patient received VAD (Vincristine, Doxorubicin, Dexamethasone) combination chemotherapy.
  • Initial response to treatment was observed, but the disease later progressed.

Findings:

  • Primary PCL is exceedingly rare in young adults.
  • The patient experienced disease progression despite initial chemotherapy response.

Related Experiment Videos

  • The case underscores the aggressive nature of PCL, even in younger individuals.

    • Implications:

    • This case highlights the importance of considering PCL in young adults presenting with aggressive hematologic conditions.
    • Further research into PCL in younger populations may reveal unique biological or clinical characteristics.
    • Understanding rare presentations is crucial for improving diagnostic and therapeutic strategies in hematologic malignancies.